Mark Geyer - Publications

Affiliations: 
University of California, San Diego, La Jolla, CA 
Area:
psychopharmacology
Website:
http://neurograd.ucsd.edu/faculty/detail.php?id=33

270 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Halberstadt AL, van der Zee JVF, Chatha M, Geyer MA, Powell SB. Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen. Psychopharmacology. PMID 30448990 DOI: 10.1007/s00213-018-5118-y  1
2018 Milienne-Petiot M, Higa KK, Grim A, Deben D, Groenink L, Twamley EW, Geyer MA, Young JW. Nicotine improves probabilistic reward learning in wildtype but not alpha7 nAChR null mutants, yet alpha7 nAChR agonists do not improve probabilistic learning. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 30213668 DOI: 10.1016/j.euroneuro.2018.08.005  0.92
2018 MacQueen DA, Minassian A, Kenton JA, Geyer MA, Perry W, Brigman JL, Young JW. Amphetamine improves mouse and human attention in the 5-choice continuous performance test. Neuropharmacology. PMID 29859849 DOI: 10.1016/j.neuropharm.2018.05.034  0.92
2018 Minassian A, Young JW, Geyer MA, Kelsoe JR, Perry W. The COMT Val158Met Polymorphism and Exploratory Behavior in Bipolar Mania. Molecular Neuropsychiatry. 3: 151-156. PMID 29594134 DOI: 10.1159/000481822  0.92
2018 Geyer MA, Semenova S, Li X, Der-Avakian A, Barnes SA, Grant I. Overview of the Biography and Legacy of Professor Athina Markou. Biological Psychiatry. PMID 29501205 DOI: 10.1016/j.biopsych.2017.10.009  0.4
2018 Phillips AG, Geyer MA, Robbins TW. Effective Use of Animal Models for Therapeutic Development in Psychiatric and Substance Use Disorders. Biological Psychiatry. PMID 29478700 DOI: 10.1016/j.biopsych.2018.01.014  0.4
2018 Stout DM, Acheson DT, Moore TM, Gur RC, Baker DG, Geyer MA, Risbrough VB. Individual variation in working memory is associated with fear extinction performance. Behaviour Research and Therapy. 102: 52-59. PMID 29331727 DOI: 10.1016/j.brat.2018.01.002  0.88
2017 Kwiatkowski MA, Hellemann G, Sugar CA, Cope ZA, Minassian A, Perry W, Geyer MA, Young JW. Dopamine transporter knockdown mice in the behavioral pattern monitor: A robust, reproducible model for mania-relevant behaviors. Pharmacology, Biochemistry, and Behavior. PMID 29289701 DOI: 10.1016/j.pbb.2017.12.007  0.92
2017 MacQueen DA, Minassian A, Henry BL, Geyer MA, Young JW, Perry W. Amphetamine Modestly Improves Conners' Continuous Performance Test Performance in Healthy Adults. Journal of the International Neuropsychological Society : Jins. 1-11. PMID 29032769 DOI: 10.1017/S135561771700090X  0.92
2017 Deslauriers J, Acheson DT, Maihofer AX, Nievergelt CM, Baker DG, Geyer MA, Risbrough VB. COMT val158met polymorphism links to altered fear conditioning and extinction are modulated by PTSD and childhood trauma. Depression and Anxiety. PMID 28833952 DOI: 10.1002/da.22678  0.88
2017 Cope ZA, Minassian A, Kreitner D, MacQueen DA, Milienne-Petiot M, Geyer MA, Perry W, Young JW. Modafinil improves attentional performance in healthy, non-sleep deprived humans at doses not inducing hyperarousal across species. Neuropharmacology. PMID 28774856 DOI: 10.1016/j.neuropharm.2017.07.031  0.92
2017 Nolte IM, Munoz ML, Tragante V, Amare AT, Jansen R, Vaez A, von der Heyde B, Avery CL, Bis JC, Dierckx B, van Dongen J, Gogarten SM, Goyette P, Hernesniemi J, Huikari V, ... ... Geyer MA, et al. Erratum: Genetic loci associated with heart rate variability and their effects on cardiac disease risk. Nature Communications. 8: 16140. PMID 28767105 DOI: 10.1038/ncomms16140  0.88
2017 Nolte IM, Munoz ML, Tragante V, Amare AT, Jansen R, Vaez A, von der Heyde B, Avery CL, Bis JC, Dierckx B, van Dongen J, Gogarten SM, Goyette P, Hernesniemi J, Huikari V, ... ... Geyer MA, et al. Genetic loci associated with heart rate variability and their effects on cardiac disease risk. Nature Communications. 8: 15805. PMID 28613276 DOI: 10.1038/ncomms15805  0.88
2017 Glenn DE, Acheson DT, Geyer MA, Nievergelt CM, Baker DG, Risbrough VB. Fear learning alterations after traumatic brain injury and their role in development of posttraumatic stress symptoms. Depression and Anxiety. PMID 28489272 DOI: 10.1002/da.22642  0.88
2017 Halberstadt AL, Geyer MA. Effect of Hallucinogens on Unconditioned Behavior. Current Topics in Behavioral Neurosciences. PMID 28224459 DOI: 10.1007/7854_2016_466  1
2017 Milienne-Petiot M, Geyer MA, Arnt J, Young JW. Brexpiprazole reduces hyperactivity, impulsivity, and risk-preference behavior in mice with dopamine transporter knockdown-a model of mania. Psychopharmacology. PMID 28160035 DOI: 10.1007/s00213-017-4543-7  0.92
2017 Deslauriers J, van Wijngaarde M, Geyer MA, Powell S, Risbrough VB. Effects of LPS-induced immune activation prior to trauma exposure on PTSD-like symptoms in mice. Behavioural Brain Research. PMID 28159589 DOI: 10.1016/j.bbr.2017.01.048  0.88
2017 Higa KK, Young JW, Ji B, Nichols DE, Geyer MA, Zhou X. Striatal dopamine D1 receptor suppression impairs reward-associative learning. Behavioural Brain Research. PMID 28143767 DOI: 10.1016/j.bbr.2017.01.041  0.92
2016 Ahmari SE, Risbrough VB, Geyer MA, Simpson HB. Prepulse Inhibition Deficits in Obsessive-Compulsive Disorder are More Pronounced in Females. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 41: 2963-2964. PMID 27818517 DOI: 10.1038/npp.2015.363  0.88
2016 Milienne-Petiot M, Kesby JP, Graves M, van Enkhuizen J, Semenova S, Minassian A, Markou A, Geyer MA, Young JW. The effects of reduced dopamine transporter function and chronic lithium on motivation, probabilistic learning, and neurochemistry in mice: Modeling bipolar mania. Neuropharmacology. PMID 27732870 DOI: 10.1016/j.neuropharm.2016.07.030  0.92
2016 Swerdlow NR, Braff DL, Geyer MA. Sensorimotor gating of the startle reflex: what we said 25 years ago, what has happened since then, and what comes next. Journal of Psychopharmacology (Oxford, England). PMID 27539931 DOI: 10.1177/0269881116661075  0.64
2016 Cope ZA, Halberstadt AL, van Enkhuizen J, Flynn AD, Breier M, Swerdlow NR, Geyer MA, Young JW. Premature responses in the five-choice serial reaction time task reflect rodents' temporal strategies: evidence from no-light and pharmacological challenges. Psychopharmacology. PMID 27534540 DOI: 10.1007/s00213-016-4389-4  1
2016 Young JW, Minassian A, Geyer MA. Locomotor Profiling from Rodents to the Clinic and Back Again. Current Topics in Behavioral Neurosciences. PMID 27418071 DOI: 10.1007/7854_2015_5015  0.92
2016 Halberstadt AL, Sindhunata I, Scheffers K, Flynn AD, Sharp RF, Geyer MA, Young JW. Effect of 5-HT2A and 5-HT2C receptors on temporal discrimination by mice. Neuropharmacology. PMID 27020041 DOI: 10.1016/j.neuropharm.2016.03.038  0.88
2016 Glenn DE, Acheson DT, Geyer MA, Nievergelt CM, Baker DG, Risbrough VB. HIGH AND LOW THRESHOLD FOR STARTLE REACTIVITY ASSOCIATED WITH PTSD SYMPTOMS BUT NOT PTSD RISK: EVIDENCE FROM A PROSPECTIVE STUDY OF ACTIVE DUTY MARINES. Depression and Anxiety. PMID 26878585 DOI: 10.1002/da.22475  0.88
2016 Steinman SA, Ahmari SE, Choo T, Kimeldorf MB, Feit R, Loh S, Risbrough V, Geyer MA, Steinglass JE, Wall M, Schneier FR, Fyer AJ, Simpson HB. PREPULSE INHIBITION DEFICITS ONLY IN FEMALES WITH OBSESSIVE-COMPULSIVE DISORDER. Depression and Anxiety. 33: 238-46. PMID 26878422 DOI: 10.1002/da.22474  0.64
2016 Higa KK, Young JW, Geyer MA. Wet or dry: translatable "water mazes" for mice and humans. The Journal of Clinical Investigation. 1-3. PMID 26784538 DOI: 10.1172/JCI86071  0.88
2015 Toth M, Flandreau EI, Deslauriers J, Geyer MA, Mansuy I, Merlo-Pich E, Risbrough V. Overexpression of Forebrain CRH During Early Life Increases Trauma Susceptibility in Adulthood. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26538448 DOI: 10.1038/npp.2015.338  0.88
2015 Minassian A, Young JW, Cope ZA, Henry BL, Geyer MA, Perry W. Amphetamine increases activity but not exploration in humans and mice. Psychopharmacology. PMID 26449721 DOI: 10.1007/s00213-015-4098-4  0.88
2015 Geyer MA. Lysergic Acid Diethylamide and Psilocybin Revisited. Biological Psychiatry. 78: 516-8. PMID 26386624 DOI: 10.1016/j.biopsych.2015.08.003  1
2015 Minassian A, Maihofer AX, Baker DG, Nievergelt CM, Geyer MA, Risbrough VB. Association of Predeployment Heart Rate Variability With Risk of Postdeployment Posttraumatic Stress Disorder in Active-Duty Marines. Jama Psychiatry. 1-8. PMID 26353072 DOI: 10.1001/jamapsychiatry.2015.0922  1
2015 van Enkhuizen J, Geyer MA, Minassian A, Perry W, Henry BL, Young JW. Investigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies. Neuroscience and Biobehavioral Reviews. PMID 26297513 DOI: 10.1016/j.neubiorev.2015.08.008  1
2015 van Enkhuizen J, Milienne-Petiot M, Geyer MA, Young JW. Modeling bipolar disorder in mice by increasing acetylcholine or dopamine: chronic lithium treats most, but not all features. Psychopharmacology. 232: 3455-67. PMID 26141192 DOI: 10.1007/s00213-015-4000-4  1
2015 Higa KK, Ji B, Buell MR, Risbrough VB, Powell SB, Young JW, Geyer MA, Zhou X. Restoration of Sp4 in Forebrain GABAergic Neurons Rescues Hypersensitivity to Ketamine in Sp4 Hypomorphic Mice. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 26037489 DOI: 10.1093/ijnp/pyv063  1
2015 Powell SB, Khan A, Young JW, Scott CN, Buell MR, Caldwell S, Tsan E, de Jong LA, Acheson DT, Lucero J, Geyer MA, Behrens MM. Early Adolescent Emergence of Reversal Learning Impairments in Isolation-Reared Rats. Developmental Neuroscience. PMID 26022788 DOI: 10.1159/000430091  1
2015 Young JW, Kamenski ME, Higa KK, Light GA, Geyer MA, Zhou X. GlyT-1 Inhibition Attenuates Attentional But Not Learning or Motivational Deficits of the Sp4 Hypomorphic Mouse Model Relevant to Psychiatric Disorders. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 25907107 DOI: 10.1038/npp.2015.120  0.48
2015 Ipser JC, Brown GG, Bischoff-Grethe A, Connolly CG, Ellis RJ, Heaton RK, Grant I. HIV infection is associated with attenuated frontostriatal intrinsic connectivity: a preliminary study. Journal of the International Neuropsychological Society : Jins. 21: 203-13. PMID 25824201 DOI: 10.1017/S1355617715000156  0.48
2015 Yurgil KA, Clifford RE, Risbrough VB, Geyer MA, Huang M, Barkauskas DA, Vasterling JJ, Baker DG. Prospective Associations Between Traumatic Brain Injury and Postdeployment Tinnitus in Active-Duty Marines. The Journal of Head Trauma Rehabilitation. PMID 25699623 DOI: 10.1097/HTR.0000000000000117  0.88
2015 Flandreau E, Risbrough V, Lu A, Ableitner M, Geyer MA, Holsboer F, Deussing JM. Cell type-specific modifications of corticotropin-releasing factor (CRF) and its type 1 receptor (CRF1) on startle behavior and sensorimotor gating. Psychoneuroendocrinology. 53: 16-28. PMID 25575243 DOI: 10.1016/j.psyneuen.2014.12.005  1
2015 Young JW, Geyer MA. Developing treatments for cognitive deficits in schizophrenia: the challenge of translation. Journal of Psychopharmacology (Oxford, England). 29: 178-96. PMID 25516372 DOI: 10.1177/0269881114555252  0.88
2015 Nievergelt CM, Maihofer AX, Mustapic M, Yurgil KA, Schork NJ, Miller MW, Logue MW, Geyer MA, Risbrough VB, O'Connor DT, Baker DG. Genomic predictors of combat stress vulnerability and resilience in U.S. Marines: A genome-wide association study across multiple ancestries implicates PRTFDC1 as a potential PTSD gene. Psychoneuroendocrinology. 51: 459-71. PMID 25456346 DOI: 10.1016/j.psyneuen.2014.10.017  0.88
2015 Acheson DT, Geyer MA, Baker DG, Nievergelt CM, Yurgil K, Risbrough VB. Conditioned fear and extinction learning performance and its association with psychiatric symptoms in active duty Marines. Psychoneuroendocrinology. 51: 495-505. PMID 25444643 DOI: 10.1016/j.psyneuen.2014.09.030  0.88
2015 Tylee DS, Chandler SD, Nievergelt CM, Liu X, Pazol J, Woelk CH, Lohr JB, Kremen WS, Baker DG, Glatt SJ, Tsuang MT. Blood-based gene-expression biomarkers of post-traumatic stress disorder among deployed marines: A pilot study. Psychoneuroendocrinology. 51: 472-94. PMID 25311155 DOI: 10.1016/j.psyneuen.2014.09.024  0.88
2015 van Enkhuizen J, Janowsky DS, Olivier B, Minassian A, Perry W, Young JW, Geyer MA. The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited. European Journal of Pharmacology. 753: 114-26. PMID 25107282 DOI: 10.1016/j.ejphar.2014.05.063  1
2015 Cattie J, Marquine MJ, Bolden KA, Obermeit LC, Morgan EE, Franklin DR, Umlauf A, Beck JM, Hampton Atkinson J, Grant I, Woods SP. Predictors of attrition in a cohort study of HIV infection and methamphetamine dependence Journal of Substance Use. DOI: 10.3109/14659891.2014.942397  0.48
2015 Van Enkhuizen J, Geyer MA, Kooistra K, Young JW. Chronic valproate attenuates some, but not ail, facets of mania-like behaviour in mice | Chronische behandeling met valproïnezuur verzwakt sommige, maar niet alle facetten van manie-achtig gedrag bij muizen Pharmaceutisch Weekblad. 150: 102-111.  0.88
2014 Connolly CG, Bischoff-Grethe A, Jordan SJ, Woods SP, Ellis RJ, Paulus MP, Grant I. Altered functional response to risky choice in HIV infection. Plos One. 9: e111583. PMID 25347679 DOI: 10.1371/journal.pone.0111583  0.48
2014 Acheson DT, Geyer MA, Risbrough VB. Psychophysiology in the study of psychological trauma: where are we now and where do we need to be? Current Topics in Behavioral Neurosciences. 21: 157-83. PMID 25158622 DOI: 10.1007/7854_2014_346  0.88
2014 van Enkhuizen J, Henry BL, Minassian A, Perry W, Milienne-Petiot M, Higa KK, Geyer MA, Young JW. Reduced dopamine transporter functioning induces high-reward risk-preference consistent with bipolar disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 3112-22. PMID 25005251 DOI: 10.1038/npp.2014.170  1
2014 Ji B, Higa KK, Kim M, Zhou L, Young JW, Geyer MA, Zhou X. Inhibition of protein translation by the DISC1-Boymaw fusion gene from a Scottish family with major psychiatric disorders. Human Molecular Genetics. 23: 5683-705. PMID 24908665 DOI: 10.1093/hmg/ddu285  0.48
2014 Minassian A, Geyer MA, Baker DG, Nievergelt CM, O'Connor DT, Risbrough VB. Heart rate variability characteristics in a large group of active-duty marines and relationship to posttraumatic stress. Psychosomatic Medicine. 76: 292-301. PMID 24804881 DOI: 10.1097/PSY.0000000000000056  1
2014 Csomor PA, Preller KH, Geyer MA, Studerus E, Huber T, Vollenweider FX. Influence of aripiprazole, risperidone, and amisulpride on sensory and sensorimotor gating in healthy 'low and high gating' humans and relation to psychometry. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 2485-96. PMID 24801767 DOI: 10.1038/npp.2014.102  1
2014 Young JW, Ratty A, Dawe GS, Geyer MA. Altered exploration and sensorimotor gating of the chakragati mouse model of schizophrenia. Behavioral Neuroscience. 128: 460-7. PMID 24708299 DOI: 10.1037/a0036425  1
2014 Patt VM, Thomas ML, Minassian A, Geyer MA, Brown GG, Perry W. Disentangling working memory processes during spatial span assessment: a modeling analysis of preferred eye movement strategies. Journal of Clinical and Experimental Neuropsychology. 36: 186-204. PMID 24499103 DOI: 10.1080/13803395.2013.877123  1
2014 van Enkhuizen J, Acheson D, Risbrough V, Drummond S, Geyer MA, Young JW. Sleep deprivation impairs performance in the 5-choice continuous performance test: similarities between humans and mice. Behavioural Brain Research. 261: 40-8. PMID 24333377 DOI: 10.1016/j.bbr.2013.12.003  1
2014 Toth M, Gresack JE, Bangasser DA, Plona Z, Valentino RJ, Flandreau EI, Mansuy IM, Merlo-Pich E, Geyer MA, Risbrough VB. Forebrain-specific CRF overproduction during development is sufficient to induce enduring anxiety and startle abnormalities in adult mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1409-19. PMID 24326400 DOI: 10.1038/npp.2013.336  1
2014 van Enkhuizen J, Geyer MA, Halberstadt AL, Zhuang X, Young JW. Dopamine depletion attenuates some behavioral abnormalities in a hyperdopaminergic mouse model of bipolar disorder. Journal of Affective Disorders. 155: 247-54. PMID 24287168 DOI: 10.1016/j.jad.2013.08.041  1
2014 Henry BL, Geyer MA, Buell MR, Perry W, Young JW, Minassian A. Prepulse inhibition in HIV-1 gp120 transgenic mice after withdrawal from chronic methamphetamine. Behavioural Pharmacology. 25: 12-22. PMID 24281153 DOI: 10.1097/FBP.0000000000000012  1
2014 Dean B, Moller HJ, Svensson TH, Geyer MA, Rujescu D, Scarr E, Millan MJ. Problems and solutions to filling the drying drug pipeline for psychiatric disorders: a report from the inaugural 2012 CINP Think Tank. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 137-48. PMID 24063634 DOI: 10.1017/S1461145713001077  1
2014 Halberstadt AL, Geyer MA. Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response. Neuropharmacology. 77: 200-7. PMID 24012658 DOI: 10.1016/j.neuropharm.2013.08.025  1
2014 Amitai N, Young JW, Higa K, Sharp RF, Geyer MA, Powell SB. Isolation rearing effects on probabilistic learning and cognitive flexibility in rats. Cognitive, Affective & Behavioral Neuroscience. 14: 388-406. PMID 23943516 DOI: 10.3758/s13415-013-0204-4  1
2013 Young JW, Geyer MA, Rissling AJ, Sharp RF, Eyler LT, Asgaard GL, Light GA. Reverse translation of the rodent 5C-CPT reveals that the impaired attention of people with schizophrenia is similar to scopolamine-induced deficits in mice. Translational Psychiatry. 3: e324. PMID 24217494 DOI: 10.1038/tp.2013.82  1
2013 Schröder S, Herker E, Itzen F, He D, Thomas S, Gilchrist DA, Kaehlcke K, Cho S, Pollard KS, Capra JA, Schnölzer M, Cole PA, Geyer M, Bruneau BG, Adelman K, et al. Acetylation of RNA polymerase II regulates growth-factor-induced gene transcription in mammalian cells. Molecular Cell. 52: 314-24. PMID 24207025 DOI: 10.1016/j.molcel.2013.10.009  0.36
2013 Devor A, Bandettini PA, Boas DA, Bower JM, Buxton RB, Cohen LB, Dale AM, Einevoll GT, Fox PT, Franceschini MA, Friston KJ, Fujimoto JG, Geyer MA, Greenberg JH, Halgren E, et al. The challenge of connecting the dots in the B.R.A.I.N. Neuron. 80: 270-4. PMID 24139032 DOI: 10.1016/j.neuron.2013.09.008  1
2013 Moore H, Geyer MA, Carter CS, Barch DM. Harnessing cognitive neuroscience to develop new treatments for improving cognition in schizophrenia: CNTRICS selected cognitive paradigms for animal models. Neuroscience and Biobehavioral Reviews. 37: 2087-91. PMID 24090823 DOI: 10.1016/j.neubiorev.2013.09.011  1
2013 Halberstadt AL, Geyer MA. Serotonergic hallucinogens as translational models relevant to schizophrenia. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 2165-80. PMID 23942028 DOI: 10.1017/S1461145713000722  1
2013 Siegel SJ, Talpos JC, Geyer MA. Animal models and measures of perceptual processing in schizophrenia. Neuroscience and Biobehavioral Reviews. 37: 2092-8. PMID 23867801 DOI: 10.1016/j.neubiorev.2013.06.016  1
2013 Young JW, Geyer MA. Evaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia. Biochemical Pharmacology. 86: 1122-32. PMID 23856289 DOI: 10.1016/j.bcp.2013.06.031  1
2013 Ji B, Wang X, Pinto-Duarte A, Kim M, Caldwell S, Young JW, Behrens MM, Sejnowski TJ, Geyer MA, Zhou X. Prolonged Ketamine Effects in Sp4 Hypomorphic Mice: Mimicking Phenotypes of Schizophrenia. Plos One. 8: e66327. PMID 23823008 DOI: 10.1371/journal.pone.0066327  1
2013 Henry BL, Minassian A, Patt VM, Hua J, Young JW, Geyer MA, Perry W. Inhibitory deficits in euthymic bipolar disorder patients assessed in the human behavioral pattern monitor. Journal of Affective Disorders. 150: 948-54. PMID 23759280 DOI: 10.1016/j.jad.2013.05.020  1
2013 Minassian A, Henry BL, Woods SP, Vaida F, Grant I, Geyer MA, Perry W. Prepulse inhibition in HIV-associated neurocognitive disorders. Journal of the International Neuropsychological Society : Jins. 19: 709-17. PMID 23552464 DOI: 10.1017/S1355617713000301  1
2013 Liu X, Hong SI, Park SJ, Dela Peña JB, Che H, Yoon SY, Kim DH, Kim JM, Cai M, Risbrough V, Geyer MA, Shin CY, Cheong JH, Park H, Lew JH, et al. The ameliorating effects of 5,7-dihydroxy-6-methoxy-2(4-phenoxyphenyl)-4H-chromene-4-one, an oroxylin A derivative, against memory impairment and sensorimotor gating deficit in mice. Archives of Pharmacal Research. 36: 854-63. PMID 23543630 DOI: 10.1007/s12272-013-0106-6  1
2013 Halberstadt AL, Geyer MA. Characterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movement. Psychopharmacology. 227: 727-39. PMID 23407781 DOI: 10.1007/s00213-013-3006-z  1
2013 Halberstadt AL, Powell SB, Geyer MA. Role of the 5-HTâ‚‚A receptor in the locomotor hyperactivity produced by phenylalkylamine hallucinogens in mice. Neuropharmacology. 70: 218-27. PMID 23376711 DOI: 10.1016/j.neuropharm.2013.01.014  1
2013 Young JW, Meves JM, Geyer MA. Nicotinic agonist-induced improvement of vigilance in mice in the 5-choice continuous performance test. Behavioural Brain Research. 240: 119-33. PMID 23201359 DOI: 10.1016/j.bbr.2012.11.028  1
2013 van Enkhuizen J, Geyer MA, Kooistra K, Young JW. Chronic valproate attenuates some, but not all, facets of mania-like behaviour in mice. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 1021-31. PMID 23164454 DOI: 10.1017/S1461145712001198  1
2013 Holstein DH, Vollenweider FX, Geyer MA, Csomor PA, Belser N, Eich D. Sensory and sensorimotor gating in adult attention-deficit/hyperactivity disorder (ADHD). Psychiatry Research. 205: 117-26. PMID 23017654 DOI: 10.1016/j.psychres.2012.08.013  1
2013 Henry BL, Geyer MA, Buell M, Perry W, Young JW, Minassian A. Behavioral effects of chronic methamphetamine treatment in HIV-1 gp120 transgenic mice. Behavioural Brain Research. 236: 210-20. PMID 22960458 DOI: 10.1016/j.bbr.2012.08.037  1
2013 van Enkhuizen J, Geyer MA, Young JW. Differential effects of dopamine transporter inhibitors in the rodent Iowa gambling task: relevance to mania. Psychopharmacology. 225: 661-74. PMID 22945515 DOI: 10.1007/s00213-012-2854-2  1
2013 Halberstadt AL, Geyer MA. Neuropharmacology of Lysergic Acid Diethylamide (LSD) and Other Hallucinogens Biological Research On Addiction. 625-635. DOI: 10.1016/B978-0-12-398335-0.00061-3  1
2012 Young JW, Amitai N, Geyer MA. Behavioral animal models to assess pro-cognitive treatments for schizophrenia. Handbook of Experimental Pharmacology. 39-79. PMID 23027412 DOI: 10.1007/978-3-642-25758-2_3  1
2012 Geyer MA, Olivier B, Joëls M, Kahn RS. From antipsychotic to anti-schizophrenia drugs: role of animal models. Trends in Pharmacological Sciences. 33: 515-21. PMID 22810174 DOI: 10.1016/j.tips.2012.06.006  1
2012 Light GA, Swerdlow NR, Rissling AJ, Radant A, Sugar CA, Sprock J, Pela M, Geyer MA, Braff DL. Characterization of neurophysiologic and neurocognitive biomarkers for use in genomic and clinical outcome studies of schizophrenia. Plos One. 7: e39434. PMID 22802938 DOI: 10.1371/journal.pone.0039434  1
2012 Ayalew M, Le-Niculescu H, Levey DF, Jain N, Changala B, Patel SD, Winiger E, Breier A, Shekhar A, Amdur R, Koller D, Nurnberger JI, Corvin A, Geyer M, Tsuang MT, et al. Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. Molecular Psychiatry. 17: 887-905. PMID 22584867 DOI: 10.1038/mp.2012.37  1
2012 Baker DG, Nash WP, Litz BT, Geyer MA, Risbrough VB, Nievergelt CM, O'Connor DT, Larson GE, Schork NJ, Vasterling JJ, Hammer PS, Webb-Murphy JA. Predictors of risk and resilience for posttraumatic stress disorder among ground combat Marines: methods of the Marine Resiliency Study. Preventing Chronic Disease. 9: E97. PMID 22575082 DOI: 10.5888/pcd9.110134  1
2012 Acheson DT, Stein MB, Paulus MP, Geyer MA, Risbrough VB. The effect of pregabalin on sensorimotor gating in 'low' gating humans and mice. Neuropharmacology. 63: 480-5. PMID 22575075 DOI: 10.1016/j.neuropharm.2012.04.018  1
2012 Swerdlow NR, Light GA, Breier MR, Shoemaker JM, Saint Marie RL, Neary AC, Geyer MA, Stevens KE, Powell SB. Sensory and sensorimotor gating deficits after neonatal ventral hippocampal lesions in rats. Developmental Neuroscience. 34: 240-9. PMID 22572564 DOI: 10.1159/000336841  1
2012 Tanaka S, Young JW, Halberstadt AL, Masten VL, Geyer MA. Four factors underlying mouse behavior in an open field. Behavioural Brain Research. 233: 55-61. PMID 22569582 DOI: 10.1016/j.bbr.2012.04.045  1
2012 Halberstadt AL, Buell MR, Price DL, Geyer MA. Differences in the locomotor-activating effects of indirect serotonin agonists in habituated and non-habituated rats. Pharmacology, Biochemistry, and Behavior. 102: 88-94. PMID 22487771 DOI: 10.1016/j.pbb.2012.03.023  1
2012 Powell SB, Weber M, Geyer MA. Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders. Current Topics in Behavioral Neurosciences. 12: 251-318. PMID 22367921 DOI: 10.1007/7854_2011_195  1
2012 Millan MJ, Agid Y, Brüne M, Bullmore ET, Carter CS, Clayton NS, Connor R, Davis S, Deakin B, DeRubeis RJ, Dubois B, Geyer MA, Goodwin GM, Gorwood P, Jay TM, et al. Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nature Reviews. Drug Discovery. 11: 141-68. PMID 22293568 DOI: 10.1038/nrd3628  1
2012 Halberstadt AL, Nichols DE, Geyer MA. Behavioral effects of α,α,β,β-tetradeutero-5-MeO-DMT in rats: comparison with 5-MeO-DMT administered in combination with a monoamine oxidase inhibitor. Psychopharmacology. 221: 709-18. PMID 22222861 DOI: 10.1007/s00213-011-2616-6  1
2012 Ahmari SE, Risbrough VB, Geyer MA, Simpson HB. Impaired sensorimotor gating in unmedicated adults with obsessive-compulsive disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1216-23. PMID 22218093 DOI: 10.1038/npp.2011.308  0.88
2012 Quednow BB, Kometer M, Geyer MA, Vollenweider FX. Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 630-40. PMID 21956447 DOI: 10.1038/npp.2011.228  1
2012 Butler PD, Chen Y, Ford JM, Geyer MA, Silverstein SM, Green MF. Perceptual measurement in schizophrenia: promising electrophysiology and neuroimaging paradigms from CNTRICS. Schizophrenia Bulletin. 38: 81-91. PMID 21890745 DOI: 10.1093/schbul/sbr106  1
2012 Young JW, Powell SB, Geyer MA. Mouse pharmacological models of cognitive disruption relevant to schizophrenia. Neuropharmacology. 62: 1381-90. PMID 21726569 DOI: 10.1016/j.neuropharm.2011.06.013  1
2011 Le-Niculescu H, Balaraman Y, Patel SD, Ayalew M, Gupta J, Kuczenski R, Shekhar A, Schork N, Geyer MA, Niculescu AB. Convergent functional genomics of anxiety disorders: translational identification of genes, biomarkers, pathways and mechanisms. Translational Psychiatry. 1: e9. PMID 22832404 DOI: 10.1038/tp.2011.9  1
2011 Le-Niculescu H, Case NJ, Hulvershorn L, Patel SD, Bowker D, Gupta J, Bell R, Edenberg HJ, Tsuang MT, Kuczenski R, Geyer MA, Rodd ZA, Niculescu AB. Convergent functional genomic studies of ω-3 fatty acids in stress reactivity, bipolar disorder and alcoholism. Translational Psychiatry. 1: e4. PMID 22832392 DOI: 10.1038/tp.2011.1  1
2011 Ott M, Geyer M, Zhou Q. The control of HIV transcription: keeping RNA polymerase II on track. Cell Host & Microbe. 10: 426-35. PMID 22100159 DOI: 10.1016/j.chom.2011.11.002  0.36
2011 Marder SR, Roth B, Sullivan PF, Scolnick EM, Nestler EJ, Geyer MA, Welnberger DR, Karayiorgou M, Guidotti A, Gingrich J, Akbarian S, Buchanan RW, Lieberman JA, Conn PJ, Haggarty SJ, et al. Advancing drug discovery for schizophrenia. Annals of the New York Academy of Sciences. 1236: 30-43. PMID 22032400 DOI: 10.1111/j.1749-6632.2011.06216.x  1
2011 Minassian A, Henry BL, Young JW, Masten V, Geyer MA, Perry W. Repeated assessment of exploration and novelty seeking in the human behavioral pattern monitor in bipolar disorder patients and healthy individuals. Plos One. 6: e24185. PMID 21912623 DOI: 10.1371/journal.pone.0024185  1
2011 Holstein DH, Csomor PA, Geyer MA, Huber T, Brugger N, Studerus E, Vollenweider FX. The effects of sertindole on sensory gating, sensorimotor gating, and cognition in healthy volunteers. Journal of Psychopharmacology (Oxford, England). 25: 1600-13. PMID 21890590 DOI: 10.1177/0269881111415734  1
2011 Tanaka S, Young JW, Gresack JE, Geyer MA, Risbrough VB. Factor analysis of attentional set-shifting performance in young and aged mice. Behavioral and Brain Functions : Bbf. 7: 33. PMID 21838910 DOI: 10.1186/1744-9081-7-33  1
2011 Chung S, Verheij MM, Hesseling P, van Vugt RW, Buell M, Belluzzi JD, Geyer MA, Martens GJ, Civelli O. The melanin-concentrating hormone (MCH) system modulates behaviors associated with psychiatric disorders. Plos One. 6: e19286. PMID 21818251 DOI: 10.1371/journal.pone.0019286  1
2011 Young JW, Meves JM, Tarantino IS, Caldwell S, Geyer MA. Delayed procedural learning in α7-nicotinic acetylcholine receptor knockout mice. Genes, Brain, and Behavior. 10: 720-33. PMID 21679297 DOI: 10.1111/j.1601-183X.2011.00711.x  1
2011 Carter CS, Barch DM, Bullmore E, Breiling J, Buchanan RW, Butler P, Cohen JD, Geyer M, Gollub R, Green MF, Jaeger J, Krystal JH, Moore H, Nuechterlein K, Robbins T, et al. Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia II: developing imaging biomarkers to enhance treatment development for schizophrenia and related disorders. Biological Psychiatry. 70: 7-12. PMID 21529781 DOI: 10.1016/j.biopsych.2011.01.041  1
2011 Young JW, Powell SB, Scott CN, Zhou X, Geyer MA. The effect of reduced dopamine D4 receptor expression in the 5-choice continuous performance task: Separating response inhibition from premature responding. Behavioural Brain Research. 222: 183-92. PMID 21458500 DOI: 10.1016/j.bbr.2011.03.054  1
2011 Young JW, van Enkhuizen J, Winstanley CA, Geyer MA. Increased risk-taking behavior in dopamine transporter knockdown mice: further support for a mouse model of mania. Journal of Psychopharmacology (Oxford, England). 25: 934-43. PMID 21421642 DOI: 10.1177/0269881111400646  1
2011 Young JW, Kooistra K, Geyer MA. Dopamine receptor mediation of the exploratory/hyperactivity effects of modafinil. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 1385-96. PMID 21412225 DOI: 10.1038/npp.2011.23  1
2011 Young JW, Henry BL, Geyer MA. Predictive animal models of mania: hits, misses and future directions. British Journal of Pharmacology. 164: 1263-84. PMID 21410454 DOI: 10.1111/j.1476-5381.2011.01318.x  1
2011 Henry BL, Minassian A, van Rhenen M, Young JW, Geyer MA, Perry W. Effect of methamphetamine dependence on inhibitory deficits in a novel human open-field paradigm. Psychopharmacology. 215: 697-707. PMID 21279333 DOI: 10.1007/s00213-011-2170-2  1
2011 Halberstadt AL, Geyer MA. Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens. Neuropharmacology. 61: 364-81. PMID 21256140 DOI: 10.1016/j.neuropharm.2011.01.017  1
2011 Tarantino IS, Sharp RF, Geyer MA, Meves JM, Young JW. Working memory span capacity improved by a D2 but not D1 receptor family agonist. Behavioural Brain Research. 219: 181-8. PMID 21232557 DOI: 10.1016/j.bbr.2010.12.037  1
2011 Halberstadt AL, Lehmann-Masten VD, Geyer MA, Powell SB. Interactive effects of mGlu5 and 5-HT2A receptors on locomotor activity in mice. Psychopharmacology. 215: 81-92. PMID 21153406 DOI: 10.1007/s00213-010-2115-1  1
2011 Halberstadt AL, Koedood L, Powell SB, Geyer MA. Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice. Journal of Psychopharmacology (Oxford, England). 25: 1548-61. PMID 21148021 DOI: 10.1177/0269881110388326  1
2011 Ali SS, Young JW, Wallace CK, Gresack J, Jeste DV, Geyer MA, Dugan LL, Risbrough VB. Initial evidence linking synaptic superoxide production with poor short-term memory in aged mice. Brain Research. 1368: 65-70. PMID 21075081 DOI: 10.1016/j.brainres.2010.11.009  1
2011 Bailer UF, Bloss CS, Frank GK, Price JC, Meltzer CC, Mathis CA, Geyer MA, Wagner A, Becker CR, Schork NJ, Kaye WH. 5-HT₁A receptor binding is increased after recovery from bulimia nervosa compared to control women and is associated with behavioral inhibition in both groups. The International Journal of Eating Disorders. 44: 477-87. PMID 20872754 DOI: 10.1002/eat.20843  1
2011 Kurian SM, Le-Niculescu H, Patel SD, Bertram D, Davis J, Dike C, Yehyawi N, Lysaker P, Dustin J, Caligiuri M, Lohr J, Lahiri DK, Nurnberger JI, Faraone SV, Geyer MA, et al. Identification of blood biomarkers for psychosis using convergent functional genomics. Molecular Psychiatry. 16: 37-58. PMID 19935739 DOI: 10.1038/mp.2009.117  1
2011 Markou A, Geyer MA. Reply to: Gamma-aminobutyric acidergic deficits cause melancholic depression: A reply to markou and geyer Biological Psychiatry. 69: e15-e16. DOI: 10.1016/j.biopsych.2010.10.001  1
2011 Young JW, Geyer MA. Using behavioral patterns across species in mood disorder research Neuromethods. 63: 21-41. DOI: 10.1007/978-1-61779-313-4_2  1
2010 Young JW, Zhou X, Geyer MA. Animal models of schizophrenia. Current Topics in Behavioral Neurosciences. 4: 391-433. PMID 21312408 DOI: 10.1007/7854_2010_62  1
2010 Markou A, Geyer MA. Studies in genetically modified mice suggest novel mechanisms of mood regulation. Biological Psychiatry. 68: 500-2. PMID 20797461 DOI: 10.1016/j.biopsych.2010.07.020  1
2010 Zhou X, Nie Z, Roberts A, Zhang D, Sebat J, Malhotra D, Kelsoe JR, Geyer MA. Reduced NMDAR1 expression in the Sp4 hypomorphic mouse may contribute to endophenotypes of human psychiatric disorders. Human Molecular Genetics. 19: 3797-805. PMID 20634195 DOI: 10.1093/hmg/ddq298  1
2010 Semenova S, Hoyer D, Geyer MA, Markou A. Somatostatin-28 modulates prepulse inhibition of the acoustic startle response, reward processes and spontaneous locomotor activity in rats. Neuropeptides. 44: 421-9. PMID 20537385 DOI: 10.1016/j.npep.2010.04.008  1
2010 Young JW, Powell SB, Geyer MA, Jeste DV, Risbrough VB. The mouse attentional-set-shifting task: a method for assaying successful cognitive aging? Cognitive, Affective & Behavioral Neuroscience. 10: 243-51. PMID 20498348 DOI: 10.3758/CABN.10.2.243  1
2010 Perry W, Minassian A, Henry B, Kincaid M, Young JW, Geyer MA. Quantifying over-activity in bipolar and schizophrenia patients in a human open field paradigm. Psychiatry Research. 178: 84-91. PMID 20471103 DOI: 10.1016/j.psychres.2010.04.032  1
2010 Gresack J, Powell S, Geyer M, Poore MS, Coste S, Risbrough V. CRF2 null mutation increases sensitivity to isolation rearing effects on locomotor activity in mice. Neuropeptides. 44: 349-53. PMID 20466421 DOI: 10.1016/j.npep.2010.04.005  1
2010 Henry BL, Minassian A, Young JW, Paulus MP, Geyer MA, Perry W. Cross-species assessments of motor and exploratory behavior related to bipolar disorder. Neuroscience and Biobehavioral Reviews. 34: 1296-306. PMID 20398694 DOI: 10.1016/j.neubiorev.2010.04.002  1
2010 Young JW, Goey AK, Minassian A, Perry W, Paulus MP, Geyer MA. The mania-like exploratory profile in genetic dopamine transporter mouse models is diminished in a familiar environment and reinstated by subthreshold psychostimulant administration. Pharmacology, Biochemistry, and Behavior. 96: 7-15. PMID 20363246 DOI: 10.1016/j.pbb.2010.03.014  1
2010 Zhou X, Chen Q, Schaukowitch K, Kelsoe JR, Geyer MA. Insoluble DISC1-Boymaw fusion proteins generated by DISC1 translocation. Molecular Psychiatry. 15: 669-72. PMID 20351725 DOI: 10.1038/mp.2009.127  1
2010 Chang WL, Geyer MA, Buell MR, Weber M, Swerdlow NR. The effects of pramipexole on prepulse inhibition and locomotor activity in C57BL/6J mice. Behavioural Pharmacology. 21: 135-43. PMID 20215963 DOI: 10.1097/FBP.0b013e328337be7e  1
2010 Young JW, Wallace CK, Geyer MA, Risbrough VB. Age-associated improvements in cross-modal prepulse inhibition in mice. Behavioral Neuroscience. 124: 133-40. PMID 20141288 DOI: 10.1037/a0018462  1
2010 Young JW, Geyer MA. Action of modafinil--increased motivation via the dopamine transporter inhibition and D1 receptors? Biological Psychiatry. 67: 784-7. PMID 20132929 DOI: 10.1016/j.biopsych.2009.12.015  1
2010 Gresack JE, Risbrough VB, Scott CN, Coste S, Stenzel-Poore M, Geyer MA, Powell SB. Isolation rearing-induced deficits in contextual fear learning do not require CRF(2) receptors. Behavioural Brain Research. 209: 80-4. PMID 20097235 DOI: 10.1016/j.bbr.2010.01.018  1
2010 Young JW, Goey AK, Minassian A, Perry W, Paulus MP, Geyer MA. GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior. Psychopharmacology. 208: 443-54. PMID 20020109 DOI: 10.1007/s00213-009-1744-8  1
2010 Hilti CC, Delko T, Orosz AT, Thomann K, Ludewig S, Geyer MA, Vollenweider FX, Feldon J, Cattapan-Ludewig K. Sustained attention and planning deficits but intact attentional set-shifting in neuroleptic-naïve first-episode schizophrenia patients. Neuropsychobiology. 61: 79-86. PMID 20016226 DOI: 10.1159/000265133  1
2010 Halberstadt AL, Geyer MA. LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor. Psychopharmacology. 208: 179-89. PMID 19937319 DOI: 10.1007/s00213-009-1718-x  1
2010 Henry BL, Minassian A, Paulus MP, Geyer MA, Perry W. Heart rate variability in bipolar mania and schizophrenia. Journal of Psychiatric Research. 44: 168-76. PMID 19700172 DOI: 10.1016/j.jpsychires.2009.07.011  1
2010 Minassian A, Henry BL, Geyer MA, Paulus MP, Young JW, Perry W. The quantitative assessment of motor activity in mania and schizophrenia. Journal of Affective Disorders. 120: 200-6. PMID 19435640 DOI: 10.1016/j.jad.2009.04.018  1
2010 Geyer MA. New opportunities in the treatment of cognitive impairments associated with schizophrenia Current Directions in Psychological Science. 19: 264-269. DOI: 10.1177/0963721410378359  1
2010 Geyer MA, Nichols DE, Vollenweider FX. Serotonin-related psychedelic drugs Encyclopedia of Neuroscience. 731-738. DOI: 10.1016/B978-008045046-9.01160-8  1
2009 Ruderman MA, Powell SB, Geyer MA. A Kappa Opioid Model of Atypical Altered Consciousness and Psychosis: U50488, DOI, AC90179 Effects on Prepulse Inhibition and Locomotion in Mice. Journal of Young Investigators. 19: 1-7. PMID 25346645  1
2009 Perry W, Minassian A, Paulus MP, Young JW, Kincaid MJ, Ferguson EJ, Henry BL, Zhuang X, Masten VL, Sharp RF, Geyer MA. A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men. Archives of General Psychiatry. 66: 1072-80. PMID 19805697 DOI: 10.1001/archgenpsychiatry.2009.58  1
2009 Suzuki G, Harper KM, Hiramoto T, Funke B, Lee M, Kang G, Buell M, Geyer MA, Kucherlapati R, Morrow B, Männistö PT, Agatsuma S, Hiroi N. Over-expression of a human chromosome 22q11.2 segment including TXNRD2, COMT and ARVCF developmentally affects incentive learning and working memory in mice. Human Molecular Genetics. 18: 3914-25. PMID 19617637 DOI: 10.1093/hmg/ddp334  1
2009 Duvvuri V, Risbrough VB, Kaye WH, Geyer MA. 5-HT1A receptor activation is necessary for 5-MeODMT-dependent potentiation of feeding inhibition. Pharmacology, Biochemistry, and Behavior. 93: 349-53. PMID 19490926 DOI: 10.1016/j.pbb.2009.05.014  1
2009 Marston HM, Young JW, Martin FD, Serpa KA, Moore CL, Wong EH, Gold L, Meltzer LT, Azar MR, Geyer MA, Shahid M. Asenapine effects in animal models of psychosis and cognitive function. Psychopharmacology. 206: 699-714. PMID 19462162 DOI: 10.1007/s00213-009-1570-z  1
2009 Zhou X, Tang W, Greenwood TA, Guo S, He L, Geyer MA, Kelsoe JR. Transcription factor SP4 is a susceptibility gene for bipolar disorder. Plos One. 4: e5196. PMID 19401786 DOI: 10.1371/journal.pone.0005196  1
2009 Powell SB, Zhou X, Geyer MA. Prepulse inhibition and genetic mouse models of schizophrenia. Behavioural Brain Research. 204: 282-94. PMID 19397931 DOI: 10.1016/j.bbr.2009.04.021  1
2009 Halberstadt AL, van der Heijden I, Ruderman MA, Risbrough VB, Gingrich JA, Geyer MA, Powell SB. 5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 1958-67. PMID 19322172 DOI: 10.1038/npp.2009.29  1
2009 Young JW, Powell SB, Risbrough V, Marston HM, Geyer MA. Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia. Pharmacology & Therapeutics. 122: 150-202. PMID 19269307 DOI: 10.1016/j.pharmthera.2009.02.004  1
2009 Suzuki G, Harper KM, Hiramoto T, Sawamura T, Lee M, Kang G, Tanigaki K, Buell M, Geyer MA, Trimble WS, Agatsuma S, Hiroi N. Sept5 deficiency exerts pleiotropic influence on affective behaviors and cognitive functions in mice. Human Molecular Genetics. 18: 1652-60. PMID 19240081 DOI: 10.1093/hmg/ddp086  1
2009 Young JW, Light GA, Marston HM, Sharp R, Geyer MA. The 5-choice continuous performance test: evidence for a translational test of vigilance for mice. Plos One. 4: e4227. PMID 19156216 DOI: 10.1371/journal.pone.0004227  1
2009 Barch DM, Carter CS, Arnsten A, Buchanan RW, Cohen JD, Geyer M, Green MF, Krystal JH, Nuechterlein K, Robbins T, Silverstein S, Smith EE, Strauss M, Wykes T, Heinssen R. Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: proceedings of the third CNTRICS meeting. Schizophrenia Bulletin. 35: 109-14. PMID 19023126 DOI: 10.1093/schbul/sbn163  1
2009 Green MF, Butler PD, Chen Y, Geyer MA, Silverstein S, Wynn JK, Yoon JH, Zemon V. Perception measurement in clinical trials of schizophrenia: promising paradigms from CNTRICS. Schizophrenia Bulletin. 35: 163-81. PMID 19023123 DOI: 10.1093/schbul/sbn156  1
2009 Risbrough VB, Geyer MA, Hauger RL, Coste S, Stenzel-Poore M, Wurst W, Holsboer F. CRF1 and CRF2 receptors are required for potentiated startle to contextual but not discrete cues. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 1494-503. PMID 19020499 DOI: 10.1038/npp.2008.205  0.88
2009 Shanahan NA, Holick Pierz KA, Masten VL, Waeber C, Ansorge M, Gingrich JA, Geyer MA, Hen R, Dulawa SC. Chronic reductions in serotonin transporter function prevent 5-HT1B-induced behavioral effects in mice. Biological Psychiatry. 65: 401-8. PMID 19013555 DOI: 10.1016/j.biopsych.2008.09.026  1
2009 Rankin CH, Abrams T, Barry RJ, Bhatnagar S, Clayton DF, Colombo J, Coppola G, Geyer MA, Glanzman DL, Marsland S, McSweeney FK, Wilson DA, Wu CF, Thompson RF. Habituation revisited: an updated and revised description of the behavioral characteristics of habituation. Neurobiology of Learning and Memory. 92: 135-8. PMID 18854219 DOI: 10.1016/j.nlm.2008.09.012  1
2009 Markou A, Chiamulera C, Geyer MA, Tricklebank M, Steckler T. Removing obstacles in neuroscience drug discovery: the future path for animal models. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 74-89. PMID 18830240 DOI: 10.1038/npp.2008.173  1
2009 Halberstadt AL, Geyer MA. Habituation and sensitization of acoustic startle: opposite influences of dopamine D1 and D2-family receptors. Neurobiology of Learning and Memory. 92: 243-8. PMID 18644244 DOI: 10.1016/j.nlm.2008.05.015  1
2008 Geyer MA, Vollenweider FX. Serotonin research: contributions to understanding psychoses. Trends in Pharmacological Sciences. 29: 445-53. PMID 19086254 DOI: 10.1016/j.tips.2008.06.006  1
2008 Geyer MA. Developing translational animal models for symptoms of schizophrenia or bipolar mania. Neurotoxicity Research. 14: 71-8. PMID 18790726 DOI: 10.1007/BF03033576  1
2008 Powell SB, Young JW, Ong JC, Caron MG, Geyer MA. Atypical antipsychotics clozapine and quetiapine attenuate prepulse inhibition deficits in dopamine transporter knockout mice. Behavioural Pharmacology. 19: 562-5. PMID 18690110 DOI: 10.1097/FBP.0b013e32830dc110  1
2008 Halberstadt AL, Buell MR, Masten VL, Risbrough VB, Geyer MA. Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors. Psychopharmacology. 201: 55-66. PMID 18604652 DOI: 10.1007/s00213-008-1247-z  1
2008 Carter CS, Barch DM, Buchanan RW, Bullmore E, Krystal JH, Cohen J, Geyer M, Green M, Nuechterlein KH, Robbins T, Silverstein S, Smith EE, Strauss M, Wykes T, Heinssen R. Identifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia Initiative. Biological Psychiatry. 64: 4-10. PMID 18466880 DOI: 10.1016/j.biopsych.2008.03.020  1
2008 Zhou X, Geyer MA, Kelsoe JR. Does disrupted-in-schizophrenia (DISC1) generate fusion transcripts? Molecular Psychiatry. 13: 361-3. PMID 18347596 DOI: 10.1038/sj.mp.4002125  1
2008 Le-Niculescu H, McFarland MJ, Ogden CA, Balaraman Y, Patel S, Tan J, Rodd ZA, Paulus M, Geyer MA, Edenberg HJ, Glatt SJ, Faraone SV, Nurnberger JI, Kuczenski R, Tsuang MT, et al. Phenomic, convergent functional genomic, and biomarker studies in a stress-reactive genetic animal model of bipolar disorder and co-morbid alcoholism. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 147: 134-66. PMID 18247375 DOI: 10.1002/ajmg.b.30707  1
2008 Doherty JM, Masten VL, Powell SB, Ralph RJ, Klamer D, Low MJ, Geyer MA. Contributions of dopamine D1, D2, and D3 receptor subtypes to the disruptive effects of cocaine on prepulse inhibition in mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 2648-56. PMID 18075489 DOI: 10.1038/sj.npp.1301657  1
2008 Jonkman S, Risbrough VB, Geyer MA, Markou A. Spontaneous nicotine withdrawal potentiates the effects of stress in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 2131-8. PMID 18033237 DOI: 10.1038/sj.npp.1301607  1
2008 Kask K, Gulinello M, Bäckström T, Geyer MA, Sundström-Poromaa I. Patients with premenstrual dysphoric disorder have increased startle response across both cycle phases and lower levels of prepulse inhibition during the late luteal phase of the menstrual cycle. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 2283-90. PMID 17940552 DOI: 10.1038/sj.npp.1301599  1
2008 Semenova S, Geyer MA, Sutcliffe JG, Markou A, Hedlund PB. Inactivation of the 5-HT(7) receptor partially blocks phencyclidine-induced disruption of prepulse inhibition. Biological Psychiatry. 63: 98-105. PMID 17531208 DOI: 10.1016/j.biopsych.2006.12.011  1
2008 Csomor PA, Stadler RR, Feldon J, Yee BK, Geyer MA, Vollenweider FX. Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 497-512. PMID 17460616 DOI: 10.1038/sj.npp.1301421  1
2007 Powell SB, Geyer MA. Overview of animal models of schizophrenia. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 9.24. PMID 18428667 DOI: 10.1002/0471142301.ns0924s39  1
2007 Young JW, Minassian A, Paulus MP, Geyer MA, Perry W. A reverse-translational approach to bipolar disorder: rodent and human studies in the Behavioral Pattern Monitor. Neuroscience and Biobehavioral Reviews. 31: 882-96. PMID 17706782 DOI: 10.1016/j.neubiorev.2007.05.009  1
2007 Harte MK, Powell SB, Swerdlow NR, Geyer MA, Reynolds GP. Deficits in parvalbumin and calbindin immunoreactive cells in the hippocampus of isolation reared rats. Journal of Neural Transmission (Vienna, Austria : 1996). 114: 893-8. PMID 17594127 DOI: 10.1007/s00702-007-0627-6  1
2007 Barboric M, Yik JH, Czudnochowski N, Yang Z, Chen R, Contreras X, Geyer M, Matija Peterlin B, Zhou Q. Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription. Nucleic Acids Research. 35: 2003-12. PMID 17341462 DOI: 10.1093/nar/gkm063  0.36
2007 Vinkers CH, Risbrough VB, Geyer MA, Caldwell S, Low MJ, Hauger RL. Role of dopamine D1 and D2 receptors in CRF-induced disruption of sensorimotor gating. Pharmacology, Biochemistry, and Behavior. 86: 550-8. PMID 17324452 DOI: 10.1016/j.pbb.2007.01.018  1
2007 Vollenweider FX, Csomor PA, Knappe B, Geyer MA, Quednow BB. The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 1876-87. PMID 17299516 DOI: 10.1038/sj.npp.1301324  1
2007 Le-Niculescu H, Balaraman Y, Patel S, Tan J, Sidhu K, Jerome RE, Edenberg HJ, Kuczenski R, Geyer MA, Nurnberger JI, Faraone SV, Tsuang MT, Niculescu AB. Towards understanding the schizophrenia code: an expanded convergent functional genomics approach. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 144: 129-58. PMID 17266109 DOI: 10.1002/ajmg.b.30481  1
2007 Kumari V, Antonova E, Geyer MA, Ffytche D, Williams SC, Sharma T. A fMRI investigation of startle gating deficits in schizophrenia patients treated with typical or atypical antipsychotics. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 10: 463-77. PMID 16923324 DOI: 10.1017/S1461145706007139  1
2007 Zhou X, Qyang Y, Kelsoe JR, Masliah E, Geyer MA. Impaired postnatal development of hippocampal dentate gyrus in Sp4 null mutant mice. Genes, Brain, and Behavior. 6: 269-76. PMID 16899055 DOI: 10.1111/j.1601-183X.2006.00256.x  1
2006 Geyer MA. The family of sensorimotor gating disorders: comorbidities or diagnostic overlaps? Neurotoxicity Research. 10: 211-20. PMID 17197371 DOI: 10.1007/BF03033358  1
2006 Krebs-Thomson K, Ruiz EM, Masten V, Buell M, Geyer MA. The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats. Psychopharmacology. 189: 319-29. PMID 17013638 DOI: 10.1007/s00213-006-0566-1  0.72
2006 McDowell JE, Brown GG, Lazar N, Camchong J, Sharp R, Krebs-Thomson K, Eyler LT, Braff DL, Geyer MA. The neural correlates of habituation of response to startling tactile stimuli presented in a functional magnetic resonance imaging environment. Psychiatry Research. 148: 1-10. PMID 17000088 DOI: 10.1016/j.pscychresns.2006.05.008  1
2006 Risbrough VB, Masten VL, Caldwell S, Paulus MP, Low MJ, Geyer MA. Differential contributions of dopamine D1, D2, and D3 receptors to MDMA-induced effects on locomotor behavior patterns in mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 2349-58. PMID 16855533 DOI: 10.1038/sj.npp.1301161  1
2006 Barr AM, Powell SB, Markou A, Geyer MA. Iloperidone reduces sensorimotor gating deficits in pharmacological models, but not a developmental model, of disrupted prepulse inhibition in rats. Neuropharmacology. 51: 457-65. PMID 16762376 DOI: 10.1016/j.neuropharm.2006.04.004  1
2006 Geyer MA. Are cross-species measures of sensorimotor gating useful for the discovery of procognitive cotreatments for schizophrenia? Dialogues in Clinical Neuroscience. 8: 9-16. PMID 16640109  1
2006 Moore H, Jentsch JD, Ghajarnia M, Geyer MA, Grace AA. A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia. Biological Psychiatry. 60: 253-64. PMID 16581031 DOI: 10.1016/j.biopsych.2006.01.003  1
2006 Vanover KE, Weiner DM, Makhay M, Veinbergs I, Gardell LR, Lameh J, Del Tredici AL, Piu F, Schiffer HH, Ott TR, Burstein ES, Uldam AK, Thygesen MB, Schlienger N, Andersson CM, ... ... Geyer MA, et al. Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R,3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine(2A) receptor inverse agonist. The Journal of Pharmacology and Experimental Therapeutics. 317: 910-8. PMID 16469866 DOI: 10.1124/jpet.105.097006  1
2006 Postma P, Gray JA, Sharma T, Geyer M, Mehrotra R, Das M, Zachariah E, Hines M, Williams SC, Kumari V. A behavioural and functional neuroimaging investigation into the effects of nicotine on sensorimotor gating in healthy subjects and persons with schizophrenia. Psychopharmacology. 184: 589-99. PMID 16456657 DOI: 10.1007/s00213-006-0307-5  1
2006 Varty GB, Powell SB, Lehmann-Masten V, Buell MR, Geyer MA. Isolation rearing of mice induces deficits in prepulse inhibition of the startle response. Behavioural Brain Research. 169: 162-7. PMID 16406103 DOI: 10.1016/j.bbr.2005.11.025  1
2006 Swerdlow NR, Geyer MA, Shoemaker JM, Light GA, Braff DL, Stevens KE, Sharp R, Breier M, Neary A, Auerbach PP. Convergence and divergence in the neurochemical regulation of prepulse inhibition of startle and N40 suppression in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 506-15. PMID 16123772 DOI: 10.1038/sj.npp.1300841  1
2005 Ong JC, Brody SA, Large CH, Geyer MA. An investigation of the efficacy of mood stabilizers in rodent models of prepulse inhibition. The Journal of Pharmacology and Experimental Therapeutics. 315: 1163-71. PMID 16123308 DOI: 10.1124/jpet.105.090845  1
2005 Floresco SB, Geyer MA, Gold LH, Grace AA. Developing predictive animal models and establishing a preclinical trials network for assessing treatment effects on cognition in schizophrenia. Schizophrenia Bulletin. 31: 888-94. PMID 16079387 DOI: 10.1093/schbul/sbi041  1
2005 Meincke U, Light GA, Geyer MA, Braff DL. On the waveform of the acoustic startle blink in the paradigm of prepulse inhibition - methodological and physiological aspects. Neuropsychobiology. 52: 24-7. PMID 15942260 DOI: 10.1159/000086174  1
2005 de Jongh R, Geyer MA, Olivier B, Groenink L. The effects of sex and neonatal maternal separation on fear-potentiated and light-enhanced startle. Behavioural Brain Research. 161: 190-6. PMID 15878207 DOI: 10.1016/j.bbr.2005.02.004  0.56
2005 Brody SA, Nakanishi N, Tu S, Lipton SA, Geyer MA. A developmental influence of the N-methyl-D-aspartate receptor NR3A subunit on prepulse inhibition of startle. Biological Psychiatry. 57: 1147-52. PMID 15866554 DOI: 10.1016/j.biopsych.2005.01.024  1
2005 Powell SB, Palomo J, Carasso BS, Bakshi VP, Geyer MA. Yohimbine disrupts prepulse inhibition in rats via action at 5-HT1A receptors, not alpha2-adrenoceptors. Psychopharmacology. 180: 491-500. PMID 15719216 DOI: 10.1007/s00213-005-2193-7  1
2005 Ludewig S, Geyer MA, Ramseier M, Vollenweider FX, Rechsteiner E, Cattapan-Ludewig K. Information-processing deficits and cognitive dysfunction in panic disorder. Journal of Psychiatry & Neuroscience : Jpn. 30: 37-43. PMID 15644996  1
2005 Risbrough VB, Geyer MA. Anxiogenic treatments do not increase fear-potentiated startle in mice. Biological Psychiatry. 57: 33-43. PMID 15607298 DOI: 10.1016/j.biopsych.2004.10.006  0.88
2004 Ogden CA, Rich ME, Schork NJ, Paulus MP, Geyer MA, Lohr JB, Kuczenski R, Niculescu AB. Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach. Molecular Psychiatry. 9: 1007-29. PMID 15314610 DOI: 10.1038/sj.mp.4001547  1
2004 Harte MK, Powell SB, Reynolds LM, Swerdlow NR, Geyer MA, Reynolds GP. Reduced N-acetylaspartate in the temporal cortex of rats reared in isolation. Biological Psychiatry. 56: 296-9. PMID 15312819 DOI: 10.1016/j.biopsych.2004.06.009  1
2004 Risbrough VB, Hauger RL, Roberts AL, Vale WW, Geyer MA. Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 6545-52. PMID 15269266 DOI: 10.1523/JNEUROSCI.5760-03.2004  1
2004 Powell SB, Geyer MA, Gallagher D, Paulus MP. The balance between approach and avoidance behaviors in a novel object exploration paradigm in mice. Behavioural Brain Research. 152: 341-9. PMID 15196802 DOI: 10.1016/j.bbr.2003.10.020  1
2004 Brody SA, Geyer MA. Interactions of the mGluR5 gene with breeding and maternal factors on startle and prepulse inhibition in mice. Neurotoxicity Research. 6: 79-90. PMID 15184109 DOI: 10.1007/BF03033300  1
2004 Meincke U, Light GA, Geyer MA, Braff DL, Gouzoulis-Mayfrank E. Sensitization and habituation of the acoustic startle reflex in patients with schizophrenia. Psychiatry Research. 126: 51-61. PMID 15081627 DOI: 10.1016/j.psychres.2004.01.003  1
2004 Powell SB, Lehmann-Masten VD, Paulus MP, Gainetdinov RR, Caron MG, Geyer MA. MDMA "ecstasy" alters hyperactive and perseverative behaviors in dopamine transporter knockout mice. Psychopharmacology. 173: 310-7. PMID 14747902 DOI: 10.1007/s00213-003-1765-7  1
2004 Brody SA, Dulawa SC, Conquet F, Geyer MA. Assessment of a prepulse inhibition deficit in a mutant mouse lacking mGlu5 receptors. Molecular Psychiatry. 9: 35-41. PMID 14699440 DOI: 10.1038/sj.mp.4001404  1
2004 Brody SA, Conquet F, Geyer MA. Effect of antipsychotic treatment on the prepulse inhibition deficit of mGluR5 knockout mice. Psychopharmacology. 172: 187-95. PMID 14615875 DOI: 10.1007/s00213-003-1635-3  1
2004 Barr AM, Lehmann-Masten V, Paulus M, Gainetdinov RR, Caron MG, Geyer MA. The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 221-8. PMID 14603268 DOI: 10.1038/sj.npp.1300343  1
2003 Geyer MA, Dulawa SC. Assessment of murine startle reactivity, prepulse inhibition, and habituation. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 8.17. PMID 18428584 DOI: 10.1002/0471142301.ns0817s24  1
2003 Brody SA, Conquet F, Geyer MA. Disruption of prepulse inhibition in mice lacking mGluR1. The European Journal of Neuroscience. 18: 3361-6. PMID 14686909 DOI: 10.1111/j.1460-9568.2003.03073.x  1
2003 Harvey PD, Geyer MA, Robbins TW, Krystal JH. Cognition in schizophrenia: from basic science to clinical treatment. Psychopharmacology. 169: 213-4. PMID 12955286 DOI: 10.1007/s00213-003-1581-0  0.4
2003 Ludewig K, Geyer MA, Vollenweider FX. Deficits in prepulse inhibition and habituation in never-medicated, first-episode schizophrenia. Biological Psychiatry. 54: 121-8. PMID 12873801 DOI: 10.1016/S0006-3223(02)01925-X  1
2003 Risbrough VB, Hauger RL, Pelleymounter MA, Geyer MA. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice. Psychopharmacology. 170: 178-87. PMID 12845406 DOI: 10.1007/s00213-003-1535-6  1
2003 Brody SA, Geyer MA, Large CH. Lamotrigine prevents ketamine but not amphetamine-induced deficits in prepulse inhibition in mice. Psychopharmacology. 169: 240-6. PMID 12698229 DOI: 10.1007/s00213-003-1421-2  1
2003 Risbrough VB, Brodkin JD, Geyer MA. GABA-A and 5-HT1A receptor agonists block expression of fear-potentiated startle in mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 654-63. PMID 12655310 DOI: 10.1038/sj.npp.1300079  0.88
2003 Powell SB, Paulus MP, Hartman DS, Godel T, Geyer MA. RO-10-5824 is a selective dopamine D4 receptor agonist that increases novel object exploration in C57 mice. Neuropharmacology. 44: 473-81. PMID 12646284 DOI: 10.1016/S0028-3908(02)00412-4  1
2003 Ralph-Williams RJ, Paulus MP, Zhuang X, Hen R, Geyer MA. Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system. Biological Psychiatry. 53: 352-9. PMID 12586455  1
2002 Powell SB, Geyer MA. Developmental markers of psychiatric disorders as identified by sensorimotor gating. Neurotoxicity Research. 4: 489-502. PMID 12754162 DOI: 10.1080/10298420290030578  1
2002 Powell SB, Swerdlow NR, Pitcher LK, Geyer MA. Isolation rearing-induced deficits in prepulse inhibition and locomotor habituation are not potentiated by water deprivation. Physiology & Behavior. 77: 55-64. PMID 12213502 DOI: 10.1016/S0031-9384(02)00817-X  1
2001 Geyer MA, Swerdlow NR. Measurement of startle response, prepulse inhibition, and habituation. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 8.7. PMID 18428548 DOI: 10.1002/0471142301.ns0807s03  0.6
2001 Ralph RJ, Paulus MP, Geyer MA. Strain-specific effects of amphetamine on prepulse inhibition and patterns of locomotor behavior in mice. The Journal of Pharmacology and Experimental Therapeutics. 298: 148-55. PMID 11408536  1
2001 Ralph RJ, Paulus MP, Fumagalli F, Caron MG, Geyer MA. Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: differential effects of D1 and D2 receptor antagonists. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 305-13. PMID 11150348  1
2000 Dulawa SC, Geyer MA. Effects of strain and serotonergic agents on prepulse inhibition and habituation in mice. Neuropharmacology. 39: 2170-9. PMID 10963760 DOI: 10.1016/S0028-3908(00)00030-7  1
2000 Palmer AA, Dulawa SC, Mottiwala AA, Conti LH, Geyer MA, Printz MP. Prepulse startle deficit in the Brown Norway rat: a potential genetic model. Behavioral Neuroscience. 114: 374-88. PMID 10832798 DOI: 10.1037//0735-7044.114.2.374  1
2000 Dulawa SC, Scearce-Levie KA, Hen R, Geyer MA. Serotonin releasers increase prepulse inhibition in serotonin 1B knockout mice. Psychopharmacology. 149: 306-12. PMID 10823412 DOI: 10.1007/s002130000373  1
2000 Varty GB, Paulus MP, Braff DL, Geyer MA. Environmental enrichment and isolation rearing in the rat: effects on locomotor behavior and startle response plasticity. Biological Psychiatry. 47: 864-73. PMID 10807959 DOI: 10.1016/S0006-3223(99)00269-3  1
2000 Dulawa SC, Gross C, Stark KL, Hen R, Geyer MA. Knockout mice reveal opposite roles for serotonin 1A and 1B receptors in prepulse inhibition. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 22: 650-9. PMID 10788764 DOI: 10.1016/S0893-133X(99)00164-5  1
2000 Paulus MP, Varty GB, Geyer MA. The genetic liability to stress and postweaning isolation have a competitive influence on behavioral organization in rats. Physiology & Behavior. 68: 389-94. PMID 10716550 DOI: 10.1016/S0031-9384(99)00193-6  1
1999 Dulawa SC, Grandy DK, Low MJ, Paulus MP, Geyer MA. Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 9550-6. PMID 10531457  1
1999 Ralph RJ, Varty GB, Kelly MA, Wang YM, Caron MG, Rubinstein M, Grandy DK, Low MJ, Geyer MA. The dopamine D2, but not D3 or D4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 4627-33. PMID 10341260  1
1999 Varty GB, Braff DL, Geyer MA. Is there a critical developmental 'window' for isolation rearing-induced changes in prepulse inhibition of the acoustic startle response? Behavioural Brain Research. 100: 177-83. PMID 10212065 DOI: 10.1016/S0166-4328(98)00129-6  1
1999 Grailhe R, Waeber C, Dulawa SC, Hornung JP, Zhuang X, Brunner D, Geyer MA, Hen R. Increased exploratory activity and altered response to LSD in mice lacking the 5-HT(5A) receptor. Neuron. 22: 581-91. PMID 10197537  1
1999 Varty GB, Bakshi VP, Geyer MA. M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 20: 311-21. PMID 10088132 DOI: 10.1016/S0893-133X(98)00072-4  1
1999 Paulus MP, Geyer MA, Braff DL. Long-range correlations in choice sequences of schizophrenic patients. Schizophrenia Research. 35: 69-75. PMID 9988842 DOI: 10.1016/S0920-9964(98)00108-X  1
1998 Dulawa SC, Hen R, Scearce-Levie K, Geyer MA. 5-HT1B receptor modulation of prepulse inhibition: recent findings in wild-type and 5-HT1B knockout mice. Annals of the New York Academy of Sciences. 861: 79-84. PMID 9928242 DOI: 10.1111/j.1749-6632.1998.tb10176.x  1
1998 Varty GB, Geyer MA. Effects of isolation rearing on startle reactivity, habituation, and prepulse inhibition in male Lewis, Sprague-Dawley, and Fischer F344 rats. Behavioral Neuroscience. 112: 1450-7. PMID 9926827 DOI: 10.1037/0735-7044.112.6.1450  1
1998 Paulus MP, Geyer MA, Sternberg E. Differential movement patterns but not amount of activity in unconditioned motor behavior of Fischer, Lewis, and Sprague-Dawley rats. Physiology & Behavior. 65: 601-6. PMID 9877429 DOI: 10.1016/S0031-9384(98)00195-4  1
1998 Paulus MP, Bakshi VP, Geyer MA. Isolation rearing affects sequential organization of motor behavior in post-pubertal but not pre-pubertal Lister and Sprague-Dawley rats. Behavioural Brain Research. 94: 271-80. PMID 9722278  1
1998 Varty GB, Hauger RL, Geyer MA. Aging effects on the startle response and startle plasticity in Fischer F344 rats. Neurobiology of Aging. 19: 243-51. PMID 9661999 DOI: 10.1016/S0197-4580(98)00053-0  1
1998 Krebs-Thomson K, Lehmann-Masten V, Naiem S, Paulus MP, Geyer MA. Modulation of phencyclidine-induced changes in locomotor activity and patterns in rats by serotonin. European Journal of Pharmacology. 343: 135-43. PMID 9570460 DOI: 10.1016/S0014-2999(97)01557-4  1
1998 Krebs-Thomson K, Paulus MP, Geyer MA. Effects of hallucinogens on locomotor and investigatory activity and patterns: influence of 5-HT2A and 5-HT2C receptors. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 18: 339-51. PMID 9536447 DOI: 10.1016/S0893-133X(97)00164-4  1
1998 Swerdlow NR, Varty GB, Geyer MA. Discrepant findings of clozapine effects on prepulse inhibition of startle: is it the route or the rat? Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 18: 50-6. PMID 9408918 DOI: 10.1016/S0893-133X(97)00110-3  1
1997 Dulawa SC, Hen R, Scearce-Levie K, Geyer MA. Serotonin1B receptor modulation of startle reactivity, habituation, and prepulse inhibition in wild-type and serotonin1B knockout mice. Psychopharmacology. 132: 125-34. PMID 9266609 DOI: 10.1007/s002130050328  1
1996 Dulawa SC, Geyer MA. Psychopharmacology of prepulse inhibition in mice. The Chinese Journal of Physiology. 39: 139-46. PMID 8955560  1
1996 Paulus MP, Geyer MA, Braff DL. Use of methods from chaos theory to quantify a fundamental dysfunction in the behavioral organization of schizophrenic patients. The American Journal of Psychiatry. 153: 714-7. PMID 8615422  1
1994 Paulus MP, Geyer MA, Braff DL. The assessment of sequential response organization in schizophrenic and control subjects. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 18: 1169-85. PMID 7846287 DOI: 10.1016/0278-5846(94)90119-8  1
1993 Paulus MP, Geyer MA. Three independent factors characterize spontaneous rat motor activity. Behavioural Brain Research. 53: 11-20. PMID 8466655 DOI: 10.1016/S0166-4328(05)80262-1  1
1993 Paulus MP, Callaway CW, Geyer MA. Quantitative assessment of the microstructure of rat behavior: II. Distinctive effects of dopamine releasers and uptake inhibitors. Psychopharmacology. 113: 187-98. PMID 7855180 DOI: 10.1007/BF02245696  1
1993 Paulus MP, Geyer MA. Quantitative assessment of the microstructure of rat behavior: I, f(d), the extension of the scaling hypothesis. Psychopharmacology. 113: 177-86. PMID 7855179 DOI: 10.1007/BF02245695  1
1992 Paulus MP, Geyer MA. The effects of MDMA and other methylenedioxy-substituted phenylalkylamines on the structure of rat locomotor activity. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 7: 15-31. PMID 1355968  1
1990 Paulus MP, Geyer MA, Gold LH, Mandell AJ. Application of entropy measures derived from the ergodic theory of dynamical systems to rat locomotor behavior. Proceedings of the National Academy of Sciences of the United States of America. 87: 723-7. PMID 1967830  1
1987 Lee EH, Wang FB, Tang YP, Geyer MA. Gabaergic interneurons in the dorsal raphe mediate the effects of apomorphine on serotonergic system. Brain Research Bulletin. 18: 345-53. PMID 2438015  0.92
1984 Geyer MA, Lee EH. Effects of clonidine, piperoxane and locus coeruleus lesion on the serotonergic and dopaminergic systems in raphe and caudate nucleus. Biochemical Pharmacology. 33: 3399-404. PMID 6437408  0.92
1984 Lee EH, Geyer MA. Dopamine autoreceptor mediation of the effects of apomorphine on serotonin neurons. Pharmacology, Biochemistry, and Behavior. 21: 301-11. PMID 6207549  0.92
1984 Lee EH, Geyer MA. Indirect effects of apomorphine on serotoninergic neurons in rats. Neuroscience. 11: 437-42. PMID 6201781  0.92
1983 Lee EH, Geyer MA. Similarities of the effects of apomorphine and 3-PPP on serotonin neurons. European Journal of Pharmacology. 94: 297-303. PMID 6653663  0.92
1982 Geyer MA, Flicker CE, Lee EH. Effects of tactile startle on serotonin content of midbrain raphe neurons in rats. Behavioural Brain Research. 4: 369-76. PMID 7073886  0.92
1982 Lee EH, Geyer MA. Selective effects of apomorphine on dorsal raphe neurons: a cytofluorimetric study. Brain Research Bulletin. 9: 719-25. PMID 6184135  0.92
1980 Lee EH, Geyer MA. Persistent effects of chronic administration of LSD on intracellular serotonin content in rat midbrain. Neuropharmacology. 19: 1005-7. PMID 7422071  0.92
1978 Geyer MA, Petersen LR, Rose GJ, Horwitt DD, Light RK, Adams LM, Zook JA, Hawkins RL, Mandell AJ. The effects of lysergic acid diethylamide and mescaline-derived hallucinogens on sensory-integrative function: tactile startle. The Journal of Pharmacology and Experimental Therapeutics. 207: 837-47. PMID 731434  1
1978 Geyer MA, Dawsey WJ, Mandell AJ. Fading: a new cytofluorimetric measure quantifying serotonin in the presence of catecholamines at the cellular level in brain. The Journal of Pharmacology and Experimental Therapeutics. 207: 650-67. PMID 309507  1
1976 Geyer MA, Puerto A, Menkes DB, Segal DS, Mandell AJ. Behavioral studies following lesions of the mesolimbic and mesostriatal serotonergic pathways. Brain Research. 106: 257-69. PMID 1276871 DOI: 10.1016/0006-8993(76)91023-4  1
1976 Hsu LL, Geyer MA, Mandell AJ. Extrapineal amine N-acetylation in rat brain. Regional and subcellular distribution and enzyme kinetics. Biochemical Pharmacology. 25: 815-9. PMID 938582 DOI: 10.1016/0006-2952(76)90152-0  1
1976 Geyer MA, Puerto A, Dawsey WJ, Knapp S, Bullard WP, Mandell AJ. Histologic and enzymatic studies of the mesolimbic and mesostriatal serotonergic pathways. Brain Research. 106: 241-56. PMID 6112 DOI: 10.1016/0002-9610(76)90164-1  1
1975 Geyer MA, Warbritton JD, Menkes DB, Zook JA, Mandell AJ. Opposite effects of intraventricular serotonin and bufotenin on rat startle responses. Pharmacology, Biochemistry, and Behavior. 3: 687-91. PMID 1187731 DOI: 10.1016/0091-3057(75)90193-8  1
1975 Geyer MA, Dawsey WJ, Mandell AJ. Differential effects of caffeine, D-amphetamine and methylphenidate on individual raphe cell fluorescence: a microspectrofluorimetric demonstration. Brain Research. 85: 135-9. PMID 1109692 DOI: 10.1016/0006-8993(75)91019-7  1
1974 Knapp S, Mandell AJ, Geyer MA. Effects of amphetamines on regional tryptophan hydroxylase activity and synaptosomal conversion of tryptophan to 5-hydroxytryptamine in rat brain. The Journal of Pharmacology and Experimental Therapeutics. 189: 676-89. PMID 4843167  1
1973 Korevaar WC, Geyer MA, Knapp S, Hsu LL, Mandell AJ. Regional distribution of 5-methyltetrahydrofolic acid in brain. Nature: New Biology. 245: 244-5. PMID 4518367  1
1972 Geyer MA, Segal DS, Mandell AJ. Effect of intraventricular infusion of dopamine and norepinephrine on motor activity. Physiology & Behavior. 8: 653-8. PMID 5038135 DOI: 10.1016/0031-9384(72)90090-X  1
Show low-probability matches.